Given the close association between NPC and Epstein–Barr virus (EBV) infection, anti‐EBV IgA serological tests, including VCA‐IgA and EBNA1‐IgA, have been recommended for NPC screening.16 This evidence concerns the gene CD79A and nasopharyngeal carcinoma.